Cargando…

Monocyte subsets in bone marrow grafts may contribute to a low incidence of acute graft‐vs‐host disease for young donors

Young donors are associated with a lower cumulative incidence of acute graft‐vs‐host disease (aGVHD) after allogenic haematopoietic stem cell transplantation (allo‐HSCT) than old donors. Although grafts are harvested from healthy donors, it is unclear whether donor age is associated with aGVHD occur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Qi, Zhao, Hong‐Yan, Yao, Wei‐Li, Zhang, Yuan‐Yuan, Fu, Hai‐Xia, Wang, Yu, Xu, Lan‐Ping, Zhang, Xiao‐Hui, Kong, Yuan, Huang, Xiao‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417711/ https://www.ncbi.nlm.nih.gov/pubmed/32608128 http://dx.doi.org/10.1111/jcmm.15557

Ejemplares similares

Donor monocyte–derived macrophages promote human acute graft-versus-host disease
por: Jardine, Laura, et al.
Publicado: (2020)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Macrophage regulation of graft-vs-host disease
por: Hong, Ya-Qun, et al.
Publicado: (2020)

Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants
por: Kong, Yuan, et al.
Publicado: (2016)

Correlation of T Cell Subsets and Hypercholesterolemia of the Donor and Its Association with Acute Graft-versus-Host Disease
por: Rivera-Franco, MM, et al.
Publicado: (2019)

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease
por: Babić, Antonija, et al.
Publicado: (2021)

Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.- host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes
Publicado: (1983)

Embryonic Stem Cells As an Alternate Marrow Donor Source: Engraftment without Graft-Versus-Host Disease
por: Burt, Richard K., et al.
Publicado: (2004)

Kinetics of T Helper Subsets and Associated Cytokines Correlate Well with the Clinical Activity of Graft-Versus-Host Disease
por: Yeh, Su-Peng, et al.
Publicado: (2012)

Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice
por: Kosugi-Kanaya, Mizuha, et al.
Publicado: (2017)

GRAFT-VS.-HOST REACTION IN TISSUE CULTURE
por: Auerbach, Robert, et al.
Publicado: (1973)

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
por: Krieger, Elizabeth, et al.
Publicado: (2020)

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
por: Chang, Ying-Jun, et al.
Publicado: (2015)

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
por: Yan, Chen-Hua, et al.
Publicado: (2016)

Serum-mediated inhibition of graft-vs.-host reaction
Publicado: (1975)

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program
por: Yang, Fan, et al.
Publicado: (2017)

An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease
por: Shao, Liang, et al.
Publicado: (2019)

Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
por: Yan, Chen-Hua, et al.
Publicado: (2019)

The Role of Micronutrients in Graft-VS.-Host Disease: Immunomodulatory Effects of Vitamins A and D
por: Chen, Xiao, et al.
Publicado: (2018)

Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow
por: Lim, Ji-Young, et al.
Publicado: (2015)

Hydrogen, a potential safeguard for graft-versus-host disease and graft ischemia-reperfusion injury?
por: Yuan, Lijuan, et al.
Publicado: (2016)

Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation
por: Kong, Yuan, et al.
Publicado: (2017)

T-Lymphocyte Subsets in the Embryonic Spleen Undergoing a Graft-Versus-Host Reaction
por: Fedecka-Bruner, Barbara, et al.
Publicado: (1991)

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance
por: Yu, Hongshuang, et al.
Publicado: (2019)

GRAFT-VS.-HOST REACTIONS IN RECIPROCAL HYBRID MICE : I. DISSOCIATION OF T-CELL ACTIVITIES IN THE MIXED LYMPHOCYTE REACTION AND TWO GRAFT-VS.-HOST ASSAYS
por: Morse, Herbert C., et al.
Publicado: (1974)

Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects
por: Meinhardt, Kathrin, et al.
Publicado: (2015)

Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes
Publicado: (1975)

Noninvasive tools based on immune biomarkers for the diagnosis of central nervous system graft-vs-host disease: Two case reports and a review of the literature
por: Lyu, Hai-Rong, et al.
Publicado: (2021)

The impact of Host vs. Graft mismatches on rejection of haploidentical bone marrow transplants in thalassemia patients using posttransplant cyclophosphamide
por: Marwah, Priya, et al.
Publicado: (2019)

Antibiotic administration exacerbates acute graft vs. host disease-induced bone marrow and spleen damage in lymphopenic mice
por: McDaniel Mims, Brianyell, et al.
Publicado: (2021)

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease
por: Villa, Nancy Y., et al.
Publicado: (2018)

Graft-vs-Host Disease Colitis After Lung Transplant
por: Kanthasamy, Kavin, et al.
Publicado: (2019)

Follicular Graft Vs Host Reaction: A Rare Presentation
por: Vashisht, Deepak, et al.
Publicado: (2020)

Biomarkers of graft-vs-host disease: Understanding and applications for the future
por: Nagasawa, Masayuki
Publicado: (2021)

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
por: Maeda, Yoshinobu, et al.
Publicado: (2019)

Incidence, Histopathological Features and Differential Diagnosis of Cutaneous Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation
por: Hacisalihoglu, Uguray Payam, et al.
Publicado: (2021)

Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease
por: Fujino, Masayuki, et al.
Publicado: (2013)

CYTOTOXICITY IN GRAFT-VERSUS-HOST REACTION : I. ROLE OF DONOR AND HOST SPLEEN CELLS
por: Singh, Jagat N., et al.
Publicado: (1972)

Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bbuqh8n80p09pu45r89jqdeq7m